Stock Quote

Addus HomeCare Announces Third Quarter 2022 Financial Results

Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2022.

Third Quarter 2022 Highlights:

  • Revenues Grow 11.0% to $240.5 Million
  • Net Income of $11.5 Million, or $0.71 per Diluted Share
  • Adjusted Earnings per Diluted Share Increases to $0.94
  • Adjusted EBITDA Increases 3.4% to $25.7 Million
  • Cash flow from operations of $18.3 Million

Overview

Net service revenues were $240.5 million for the third quarter of 2022, an 11.0% increase compared with $216.7 million for the third quarter of 2021. Net income was $11.5 million for the third quarter of 2022, compared with $11.6 million for the third quarter of 2021, while net income per diluted share was $0.71 compared with $0.72 for the same period a year ago. Adjusted EBITDA increased 3.4% to $25.7 million for the third quarter of 2022 from $24.9 million for the third quarter of 2021. Adjusted net income per diluted share was $0.94 for the third quarter of 2022 compared with $0.91 for the third quarter of 2021. Adjusted net income per diluted share for the third quarter of 2022 excludes acquisition and de novo expenses of $0.08, restructure and other non-recurring costs of $0.01 and stock-based compensation expense of $0.14. (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

For the first nine months of 2022, net service revenues increased 10.0% to $704.1 million from $639.9 million for the prior-year period. Net income was $31.3 million for the first nine months of 2022 compared with $32.1 million for the same period in 2021, and net income per diluted share was $1.94 compared with $2.00 per diluted share. Adjusted net income was $42.3 million compared with $42.0 million for the first nine months of 2021, while adjusted net income per diluted share was $2.63 compared with $2.62 for the prior-year period. Adjusted EBITDA increased 4.7% to $73.2 million for the first nine months of 2022 from $69.9 million for the first nine months of 2021.

Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus continues to produce strong financial and operating results, and we were pleased with our ability to execute on our strategy in the current environment. Our overall revenue growth of 11.0% over the third quarter of the prior year reflects favorable trends in each of our operating segments. Personal care revenues, which accounted for 74.5% of overall revenue, were up 7.0% on a same-store basis. For our home health business, we achieved an 18.6% organic growth rate in new admissions and total volumes were up 15.1% on a same store basis. Total home health revenues increased 25.1% from the prior year and include the addition of the operations of Armada Home Health and Summit Home Health that were both acquired in 2021. We are excited about the growth opportunities in our home health operations as it complements our personal care services and supports our value-based care models. We also saw steady improvement in our hospice business, which accounted for 21.4% of revenues for the third quarter and included the acquired operations of JourneyCare, which were added as of February 1, 2022, and are now fully integrated. Total hospice revenues were up 31.4% over the third quarter of 2021, and our median length of stay increased from 23 days in the second quarter to 28 days in the third quarter.

“As we end the third quarter, we are proud of the excellent job our team has done to date during 2022 despite various challenges, including the impact of Omicron, which was especially acute during the first quarter, and industry-wide staffing headwinds throughout the year. While the clinical recruiting and retention dynamics remain challenging, we are seeing clinical hiring trends start to move in a positive direction. Our overall hiring and turnover trends in personal care have also continued to improve during the third quarter, and we continue to evaluate and invest in enhancing our recruiting and onboarding processes to best position Addus to meet current and expected demand for our services.

“We remain strategic in our efforts to grow our existing business organically while actively pursuing additional growth through acquisitions. On October 1, 2022, we completed the acquisition of Apple Home Healthcare, LTD (“Apple”), which serves an average daily census of approximately 450 home health patients in an 11-county area in and around Chicago, Illinois. This transaction aligns with our strategy of expanding clinical services in existing personal care markets so that we can provide all three levels of home care with geographic scale and density. Together with our recent acquisitions of Summit Home Health and JourneyCare Hospice in the greater Chicago area, we have extended our market coverage in both clinical care segments. We are excited to welcome the experienced Apple operations team and clinical staff to Addus, and we look forward to serving more patients in this important market.”

Cash and Liquidity

The Company has focused on maintaining a strong financial position in 2022. As of September 30, 2022, the Company had cash of $105.6 million, with capacity and availability under its revolving credit facility of $375.5 million and $200.5 million, respectively. Net cash provided by operating activities was $18.3 million for the third quarter of 2022.

Looking Ahead

Allison added, “We are pleased with the trends in our business and believe that we are well positioned to drive further growth. With the completion of the Apple transaction, we have added approximately $65 million in annualized revenues through acquisitions to date in 2022. Our experienced and capable development team has assembled a robust pipeline of acquisition opportunities, and we have the capital structure and liquidity to support our growth strategy and further strengthen our competitive market position.

“We remain especially proud of our team’s dedicated work, particularly our frontline caregivers, who provide outstanding care and support for our patients and their families. They continue to respond to the growing demand for our services, delivered in the safest and most cost-effective setting. We have a proven operating model across the care continuum that supports favorable outcomes and patient satisfaction. We believe we are well positioned to build on this model, and we look forward to the opportunities ahead for Addus,” said Allison.

Non-GAAP Financial Measures

The information provided in this release includes adjusted net income, adjusted EBITDA and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition and de novo expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defines adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defines adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defined adjusted net income, adjusted EBITDA, adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted earnings per share to earnings per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted earnings per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.

Conference Call

Addus will host a conference call on Tuesday, November 1, 2022, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on November 8, 2022, by dialing 1-877-344-7529 (international dial-in number is (412) 317-0088) and entering pass code 4223751.

A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, anticipated transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any future impact to our business operations, reimbursements and patient population due to the recent COVID-19 global pandemic, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 25, 2022, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals. Addus HomeCare currently provides home care services to approximately 46,500 consumers through 207 locations across 22 states. For more information, please visit www.addus.com.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(amounts and shares in thousands, except per share data)
(Unaudited)
 

For the Three Months

For the Nine Months

Income Statement Information:

Ended September 30,

Ended September 30,

2022

2021

2022

2021

 
Net service revenues

$

240,495

 

$

216,662

 

$

704,070

 

$

639,857

 

Cost of service revenues

 

165,310

 

 

149,616

 

 

483,100

 

 

442,804

 

 

Gross profit

 

75,185

 

 

67,046

 

 

220,970

 

 

197,053

 

 

31.3

%

 

30.9

%

 

31.4

%

 

30.8

%

General and administrative expenses

 

54,228

 

 

46,280

 

 

162,476

 

 

139,881

 

Depreciation and amortization

 

3,441

 

 

3,406

 

 

10,571

 

 

10,594

 

Total operating expenses

 

57,669

 

 

49,686

 

 

173,047

 

 

150,475

 

 

Operating income

 

17,516

 

 

17,360

 

 

47,923

 

 

46,578

 

 

Total interest expense, net

 

2,389

 

 

1,577

 

 

6,029

 

 

4,002

 

 

Income before income taxes

 

15,127

 

 

15,783

 

 

41,894

 

 

42,576

 

Income tax expense

 

3,584

 

 

4,206

 

 

10,631

 

 

10,508

 

 

Net income

$

11,543

 

$

11,577

 

$

31,263

 

$

32,068

 

 

Net income per diluted share:

$

0.71

 

$

0.72

 

$

1.94

 

$

2.00

 

 

 

Weighted average number of common shares outstanding:

 

Diluted

 

16,184

 

 

16,030

 

 

16,146

 

 

16,060

 

 

 

 

 

For the Three Months

For the Nine Months

Cash Flow Information:

Ended September 30,

Ended September 30,

2022

2021

2022

2021

 

Net cash provided by operating activities

$

18,316

 

$

17,608

 

$

80,818

 

$

14,287

 

Net cash (used in) investing activities

 

(1,326

)

 

(30,505

)

 

(87,354

)

 

(32,433

)

Net cash (used in) provided by financing activities

 

(32,263

)

 

25,876

 

 

(56,715

)

 

25,447

 

 

Net change in cash

 

(15,273

)

 

12,979

 

 

(63,251

)

 

7,301

 

Cash at the beginning of the period

 

120,917

 

 

139,400

 

 

168,895

 

 

145,078

 

Cash at the end of the period

$

105,644

 

$

152,379

 

$

105,644

 

$

152,379

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Amounts in thousands)
(Unaudited)
 
 
 
September 30,

2022

2021

 
Assets
 
Current assets
Cash

$

105,644

$

152,379

Accounts receivable, net

 

126,253

 

133,814

Prepaid expenses and other current assets

 

8,245

 

13,514

 
Total current assets

 

240,142

 

299,707

 
Property and equipment, net

 

17,428

 

18,614

 
Other assets
Goodwill

 

575,205

 

497,919

Intangible assets, net

 

72,655

 

66,332

Deferred tax assets, net

 

-

 

5,919

Operating lease assets

 

40,503

 

36,424

Total other assets

 

688,363

 

606,594

 
Total assets

$

945,933

$

924,915

 
Liabilities and stockholders' equity
 
Current liabilities
Accounts payable

$

19,545

$

23,167

Accrued payroll

 

35,084

 

31,626

Accrued expenses

 

39,557

 

35,780

Government stimulus advance

 

21,158

 

7,674

Accrued workers compensation

 

12,844

 

14,286

Total current liabilities

 

128,188

 

112,533

 
Long-term debt, less current portion, net of debt issuance costs

 

163,557

 

220,707

Long-term lease liability, less current portion

 

37,168

 

33,509

Other long-term liabilities

 

2,183

 

115

Total long-term liabilities

 

202,908

 

254,331

 
Total liabilities

 

331,096

 

366,864

 
Total stockholders' equity

 

614,837

 

558,051

 
Total liabilities and stockholders' equity

$

945,933

$

924,915

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Net Service Revenue by Segment
(Amounts in thousands)
(Unaudited)
 
 
 

For the Three Months

For the Nine Months

Ended September 30,

Ended September 30,

2022

2021

2022

2021

Net Service Revenues by Segment
 
Personal Care

$

179,180

$

169,609

$

523,142

$

510,744

Hospice

 

51,359

 

39,095

 

151,160

 

112,098

Home Health

 

9,956

 

7,958

 

29,768

 

17,015

Total Revenue

$

240,495

$

216,662

$

704,070

$

639,857

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Key Statistical and Financial Data (Unaudited)
 

For the Three Months

For the Nine Months

Ended September 30,

Ended September 30,

2022

2021

2022

2021

Personal Care
 
States served at period end

 

-

 

 

-

 

 

21

 

22

 

Locations at period end

 

-

 

 

-

 

 

161

 

162

 

Average billable census total

 

37,677

 

 

37,979

 

 

37,253

 

38,266

 

Billable hours (in thousands)

 

7,473

 

 

7,537

 

 

21,947

 

22,712

 

Average billable hours per census per month

 

65.9

 

 

65.8

 

 

65.2

 

65.7

 

Billable hours per business day

 

113,229

 

 

114,195

 

 

112,547

 

116,472

 

Revenues per billable hour

$

23.92

 

$

22.47

 

$

23.71

 

$ 22.45

 

Organic growth
- Revenue

 

7.0

%

 

4.0

%

 

3.5

%

6.6

%
 
Hospice
 
Locations served at period end

 

-

 

 

-

 

 

33

 

34

 

Admissions

 

3,182

 

 

2,565

 

 

9,778

 

7,211

 

Average daily census

 

3,280

 

 

2,629

 

 

3,304

 

2,523

 

Average discharge length of stay

 

92.7

 

 

95.2

 

 

86.8

 

95.4

 

Patient days

 

301,797

 

 

240,692

 

 

880,574

 

680,600

 

Revenue per patient day

$

170.18

 

$

162.43

 

$

171.66

 

$ 164.71

 

Organic growth
- Revenue

 

0.1

%

 

(4.8

)%

 

1.6

%

(7.2

)%

- Average daily census

 

2.2

%

 

(7.6

)%

 

5.0

%

(24.6

)%

 
Home Health
 
Locations served at period end

 

-

 

 

-

 

 

12

 

11

 

New Admissions

 

3,684

 

 

2,608

 

 

10,371

 

4,962

 

Recertifications

 

1,482

 

 

1,081

 

 

4,207

 

2,476

 

Total Volume

 

5,166

 

 

3,689

 

 

14,578

 

7,438

 

Visits

 

71,670

 

 

55,963

 

 

205,335

 

115,210

Organic growth
- Revenue

 

0.2

%

 

24.8

%

 

(1.2

)%

15.9

%

- New admissions

 

18.6

%

 

27.9

%

 

15.7

%

23.8

%
- Volume

 

15.1

%

 

29.8

%

 

16.0

%

18.2

%
 
Percentage of Revenues by Payor:
 
Personal Care
 
State, local and other governmental programs

 

49.4

%

 

49.5

%

 

49.4

%

49.5

%
Managed care organizations

 

46.4

 

 

45.3

 

 

46.1

 

45.3

 

Private duty

 

2.6

 

 

2.9

 

 

2.6

 

2.9

Commercial

 

1.0

 

 

1.4

 

 

1.1

 

1.5

 

Other

 

0.6

%

 

0.9

%

 

0.8

%

0.8

%
 
Hospice
 
Medicare

 

90.6

%

 

92.8

%

 

90.8

%

93.4

%

Commercial

 

5.4

 

 

3.0

 

 

5.1

 

2.4

Managed care organizations

 

3.5

 

 

3.9

 

 

3.6

 

3.9

 

Other

 

0.5

%

 

0.3

%

 

0.5

%

0.3

%

 
Home Health
 
Medicare

 

73.5

%

 

80.1

%

 

73.0

%

80.5

%

Managed care organizations

 

20.1

 

 

15.3

 

 

20.7

 

16.7

Commercial

 

6.2

 

 

4.4

 

 

6.1

 

2.8

 

Other

 

0.2

%

 

0.2

%

 

0.2

%

0.0

%

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Reconciliation of Non-GAAP Financial Measures
(amounts in thousands, except per share data)
(Unaudited) (1)
 
 

For the Three Months

For the Nine Months

Ended September 30,

Ended September 30,

2022

2021

2022

2021

Reconciliation of Adjusted EBITDA to Net Income: (2)
 
Net income

$

11,543

 

$

11,577

 

$

31,263

 

$

32,068

 

 
Interest expense, net

 

2,389

 

 

1,577

 

 

6,029

 

 

4,002

 

(Gain) Loss on sale of assets

 

(25

)

 

-

 

 

(27

)

 

16

 

Income tax expense

 

3,584

 

 

4,206

 

 

10,631

 

 

10,508

 

Depreciation and amortization

 

3,441

 

 

3,406

 

 

10,571

 

 

10,594

 

COVID-19 expense, net

 

-

 

 

-

 

 

-

 

 

(591

)

Acquisition and de novo expenses

 

1,878

 

 

1,663

 

 

6,502

 

 

5,383

 

Stock-based compensation expense

 

2,780

 

 

2,341

 

 

7,945

 

 

7,105

 

Restructure and other non-recurring costs

 

132

 

 

103

 

 

318

 

 

857

 

Adjusted EBITDA

$

25,722

 

$

24,873

 

$

73,232

 

$

69,942

 

 
Reconciliation of Adjusted Net Income to Net Income: (3)
 
Net income

$

11,543

 

$

11,577

 

$

31,263

 

$

32,068

 

 
(Gain) Loss on sale of assets, net of tax

 

(18

)

 

-

 

 

(20

)

 

12

 

COVID-19 expense, net of tax

 

-

 

 

-

 

 

-

 

 

(479

)

Acquisition and de novo expenses, net of tax

 

1,444

 

 

1,220

 

 

4,852

 

 

4,361

 

Stock-based compensation expense, net of tax

 

2,124

 

 

1,716

 

 

5,928

 

 

5,370

 

Restructure and other non-recurring costs, net of tax

 

101

 

 

76

 

 

237

 

 

647

 

 
Adjusted Net Income

$

15,194

 

$

14,589

 

$

42,260

 

$

41,979

 

 
 
Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (4)
 
Net income per diluted share

$

0.71

 

$

0.72

 

$

1.94

 

$

2.00

 

 
COVID-19 expense, net per diluted share

 

-

 

 

-

 

 

-

 

 

(0.02

)

Acquisition and de novo expenses per diluted share

 

0.08

 

 

0.08

 

 

0.30

 

 

0.27

 

Restructure and other non-recurring costs per diluted share

 

0.01

 

 

-

 

 

0.01

 

 

0.04

 

Stock-based compensation expense per diluted share

 

0.14

 

 

0.11

 

 

0.38

 

 

0.33

 

 
Adjusted net income per diluted share

$

0.94

 

$

0.91

 

$

2.63

 

$

2.62

 

 
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (5)
 
Net service revenues

$

240,495

 

$

216,662

 

$

704,070

 

$

639,857

 

 
Revenues associated with the closure of certain sites

 

0

 

 

(529

)

 

0

 

 

(1,816

)

 
Adjusted net service revenues

$

240,495

 

$

216,133

 

$

704,070

 

$

638,041

 

 
 
Footnotes:
(1) The Company defined adjusted net income, adjusted EBITDA, and adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021.
(2) We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from Illinois. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(3) We define Adjusted Net Income as net income before acquisition and de novo expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from Illinois. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(4) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from Illinois. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(5) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.